IRIS
D'ANNA, Rosario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.591
EU - Europa 9.360
AS - Asia 4.324
SA - Sud America 1.521
Continente sconosciuto - Info sul continente non disponibili 273
AF - Africa 134
OC - Oceania 17
Totale 25.220
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.319
RU - Federazione Russa 4.668
SG - Singapore 1.784
CN - Cina 1.360
BR - Brasile 1.289
IE - Irlanda 1.030
SE - Svezia 1.027
IT - Italia 739
HK - Hong Kong 442
DE - Germania 435
UA - Ucraina 317
FR - Francia 308
VN - Vietnam 236
PL - Polonia 215
GB - Regno Unito 208
FI - Finlandia 206
IN - India 115
CA - Canada 112
AR - Argentina 84
BD - Bangladesh 65
MX - Messico 51
BE - Belgio 42
ZA - Sudafrica 40
JP - Giappone 38
EC - Ecuador 36
TR - Turchia 36
NL - Olanda 34
IQ - Iraq 31
UZ - Uzbekistan 26
CO - Colombia 24
ES - Italia 24
ID - Indonesia 24
MA - Marocco 23
PK - Pakistan 23
AT - Austria 22
VE - Venezuela 22
JM - Giamaica 18
IR - Iran 17
CR - Costa Rica 16
PH - Filippine 16
CZ - Repubblica Ceca 15
GT - Guatemala 15
UY - Uruguay 15
AU - Australia 14
EG - Egitto 14
TN - Tunisia 14
AL - Albania 13
PE - Perù 13
PY - Paraguay 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
HN - Honduras 12
LT - Lituania 11
KE - Kenya 10
MY - Malesia 10
SV - El Salvador 10
AZ - Azerbaigian 9
SA - Arabia Saudita 9
BO - Bolivia 8
KZ - Kazakistan 8
PR - Porto Rico 8
RO - Romania 8
JO - Giordania 7
KR - Corea 7
TT - Trinidad e Tobago 7
CI - Costa d'Avorio 6
DO - Repubblica Dominicana 6
IL - Israele 6
OM - Oman 6
GY - Guiana 5
KH - Cambogia 5
NI - Nicaragua 5
RS - Serbia 5
SN - Senegal 5
AM - Armenia 4
DZ - Algeria 4
EE - Estonia 4
LB - Libano 4
LU - Lussemburgo 4
MN - Mongolia 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
CH - Svizzera 3
ET - Etiopia 3
GP - Guadalupe 3
GR - Grecia 3
LV - Lettonia 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SC - Seychelles 3
BN - Brunei Darussalam 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CW - ???statistics.table.value.countryCode.CW??? 2
GE - Georgia 2
MD - Moldavia 2
NO - Norvegia 2
Totale 24.921
Salva come PNG Salva come JPEG
Città #
Ashburn 1.573
Moscow 1.305
Singapore 1.036
Dublin 1.030
Chandler 736
Dallas 700
Jacksonville 651
San Jose 531
Nyköping 513
Beijing 488
Hong Kong 441
Council Bluffs 284
Warsaw 201
The Dalles 189
Messina 187
Los Angeles 174
Princeton 170
Boardman 163
Lauterbourg 160
Cambridge 157
Medford 153
Dearborn 145
Ann Arbor 139
Des Moines 128
São Paulo 104
Munich 101
New York 87
Buffalo 86
Santa Clara 83
Ho Chi Minh City 80
Jinan 58
Hanoi 53
Woodbridge 53
Atlanta 50
Frankfurt am Main 46
Wilmington 45
Redondo Beach 42
Guangzhou 41
Tianjin 41
Shenyang 40
Brussels 39
Orem 39
Phoenix 39
Belo Horizonte 37
Catania 37
Turku 35
San Mateo 33
Brooklyn 32
Milan 32
Rio de Janeiro 32
London 31
Bremen 30
Tokyo 30
Zhengzhou 30
Denver 29
Hyderabad 29
Lancaster 29
Düsseldorf 28
Houston 28
North Bergen 28
Chicago 27
Curitiba 27
Hebei 26
Montreal 26
Rome 26
Columbus 25
Shanghai 25
Porto Alegre 24
Seattle 24
Brasília 23
Chennai 23
Helsinki 23
Tashkent 22
Boston 21
Johannesburg 21
Ningbo 21
San Francisco 20
Shenzhen 20
Nanjing 19
Stockholm 19
Haikou 17
Ottawa 17
Pune 17
Taizhou 17
Washington 17
Manchester 15
Sorocaba 15
Baghdad 14
Dong Ket 14
Fortaleza 13
Guayaquil 13
Mexico City 13
Quito 13
Campinas 12
Guarulhos 12
Guatemala City 12
Kingston 12
Montevideo 12
Naples 12
Norwalk 12
Totale 13.652
Salva come PNG Salva come JPEG
Nome #
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 358
Inositolo e sindrome metabolica in menopausa 305
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 302
Dietary management of skin health: The role of genistein 274
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 267
Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women - A randomized trial 251
Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study 250
Antiviral activity of Ellagic acid and Annona Muricata in cervical HPV related pre-neoplastic lesions: A randomized trial 242
Adiponectin and insulin resistance in early- and late-onset pre-eclampsia 241
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 237
Myo-inositol and melatonin in the menopausal transition 231
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 229
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 229
Italian risk factor-based screening for gestational diabetes. 220
A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. 220
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 218
Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study 217
Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. 217
Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and Placebo-controlled Study 214
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 212
Bone remodeling and regulation of sRANKL/OPG balance after genistein administration in osteopenic, postmenopausal women 210
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 209
Abnormal glucose tolerance later in life in women affected by glucose intolerance during pregnancy 208
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 206
Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension 203
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 202
A New Supplement for the Treatment of Metabolic Syndrome in Postmenopausal Women 202
Myo-inositol may prevent gestational diabetes in PCOS women 201
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 200
C-reactive protein as an early predictor of gestational diabetes mellitus 194
OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration. 194
Cardiovascular effects of raloxifene hydrochloride 193
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo controlled study. 193
Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: A two-year randomized, double-blind, placebo-controlled study 192
Cardiac diastolic evaluation in pregnant women with abnormal glucose tolerance: an opportunity to detect the early and subclinical alterations and prevent cardiovascular diseases 191
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 189
Effects of myo-inositol on glucose variability in women with gestational diabetes 188
GENISTEIN AGLYCONE DOES NOT AFFECT THYROID FUNCTION: RESULTS FROM A THREE-YEAR, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 185
Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study 183
B cell leukaemia/lymphoma-2 protein concentrations during normal pregnancy 181
Closed vs. Open Oocyte Vitrification Methods Are Equally Effective for Blastocyst Embryo Transfers: Prospective Study from a Sibling Oocyte Donation Program 181
First trimester serum neutrophil gelatinase-associated lipocalin in gestational diabetes 180
Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions 179
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 179
Cardiovascular effects of the phytoestrogen genistein 176
Neutrophil gelatinase-associated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. 176
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 176
Myo-inositol supplementation reduces the amount of gonadotropins and length of ovarian stimulation in women undergoing IVF: a systematic review and meta-analysis of randomized controlled trials 175
Association of maternal food insecurity before and during pregnancy with fetal structural anomalies: A multicenter case-control study protocol 175
Positive association between a single abnormal glucose tolerance test value in pregnancy and subsequent abnormal glucose tolerance 174
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 174
Plasma homocysteine in early and late pregnancies complicated with preeclampsia and isolated intrauterine growth restriction 173
Myo-inositol supplementation and the onset of gestational diabetes mellitus in pregnant women with a family hystory of type 2 diabetes. A prospective, randomized, placebo controlled study 172
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 171
Improvement of selective screening strategy for gestational diabetes through a more accuratedefinition of high-risk groups 170
EFFECTS OF THE PHYTOESTROGEN GENISTEIN ON CARDIOVASCULAR RISK FACTORS IN POSTMENOPAUSAL WOMEN. 170
Compliance with hormone replacement therapy in postmenopausal Sicilian women 169
ADAM 12 come marker precoce di preeclampsia 169
Myo-inositol supplementation to prevent gestational diabetes in overweight non-obese women: bioelectrical impedance analysis, metabolic aspects, obstetric and neonatal outcomes–a randomized and open-label, placebo-controlled clinical trial 168
Maternal serum PAPP-A as an early marker of obstetric complications? 167
CORRESPONDENCE BETWEEN FIRST TRIMESTER FASTING GLICEMIA AND ORAL GLUCOSE TOLERANCE TEST IN GESTATIONAL DIABETES DIAGNOSIS 166
ICAM-1 in maternal serum and amniotic fluid as an early marker of preeclampsia and IUGR 164
Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders 162
Is mid-trimester maternal serum inhibin-A a marker of preeclampsia or intrauterine growth restriction? 161
Differenze socio.demografiche e psicologiche tra gruppi di pazienti in peri e post menopausa 161
Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study 160
Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia. 159
Midtrimester amniotic fluid adiponectin in normal pregnancy. 158
Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappa B ligand-osteoprotegerin system in early postmenopausal women 157
Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy 155
Pregnancy outcome following mid-trimester amniocentesis 153
SICUREZZA ED EFFICACIA DELLA GENISTEINA IN DONNE OSTEOPENICHE IN POSTMENOPAUSA 152
Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study 152
Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women 152
Effetti del fitoestrogeno genisteina su donne in post-menopausa affette da sindrome metabolica 151
Second trimester neutrophil gelatinase-associated lipocalin as a potential prediagnostic marker of preeclampsia. 150
Effects of prepregnancy body mass index and weight gain during pregnancy on perinatal outcome in glucose-tolerant women. 150
Effects of a new vaginal cream containing visnadine, prenylflavonoids and bovine colostrum on Vaginal Health Index Score and Female Sexual Function Index in post-menopausal sexually active women affected by vaginal dryness: A pilot study 150
Myoinositol plus α‑lactalbumin supplementation, insulin resistance and birth outcomes in women with gestational diabetes mellitus: a randomized, controlled study 149
Effects of genistein aglycone on endometrial hyperplasia in premenopausal women: a randomized controlled trial 148
The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats 148
Midtrimester Amniotic Fluid Leptin and Insulin Levels and Subsequent Gestational Diabetes. 146
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 146
Anti-SARS-CoV2 IgG are present in the amniotic fluid of both infected and vaccinated women at second trimester of pregnancy: a cohort study 144
First- and Second-Trimester ADAM12s in Down Syndrome Screening. 143
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 142
La disfunzione diastolica nel diabete gestazionale 141
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 141
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 140
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 140
Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study 139
Myo-Inositol for the Prevention of Gestational Diabetes Mellitus. A Brief Review 139
Prevalence of risk factors in the screening of carbohydrate intolerance in pregnancy 137
Prevalenza dei fattori di rischio associati al diabete gestazionale e alla ridotta tolleranza glucidica in gravidanza 136
The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women 130
The steady-state serum concentration of genistein aglycone is affected by formulation: a bioequivalence study of bone products. 126
Inflammatory markers in women with a recent history of gestational diabetes mellitus 124
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 123
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS 122
The impact of kidney development on the life course: a consensus document for action 122
Totale 18.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 84.114
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.114
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022987 0 0 0 0 47 15 70 44 35 282 148 346
2022/20233.036 223 283 149 185 252 300 33 177 1.289 16 96 33
2023/2024770 60 108 43 106 62 111 27 30 0 58 21 144
2024/20253.387 68 29 70 221 147 132 54 717 850 238 325 536
2025/202610.784 595 724 733 759 811 2.217 1.282 1.359 1.458 422 186 238
2026/20272.449 221 835 569 795 29 0 0 0 0 0 0 0
Totale 25.220